Richard Vosser

Stock Analyst at JP Morgan

(1.53)

# 3,454

Out of 4,944 analysts

11

Total ratings

62.5%

Success rate

-1.58%

Average return

Main Sectors:

Top Industries:

Drug Manufacturers - General Biotechnology

Stocks Rated by Richard Vosser

	Stock	Action	Price Target	Current	Upside	Ratings	Updated
	SNY Sanofi	Upgrades: Overweight	n/a	$48.74	-	3	Aug 8, 2025
	MOLN Molecular Partners AG	Maintains: Neutral	$6.6 → $4.5	$3.56	+26.49%	1	Dec 5, 2023
	NVO Novo Nordisk	Upgrades: Overweight	n/a	$50.90	-	7	Jun 7, 2022

Sanofi

Aug 8, 2025

Upgrades: Overweight

Price Target: n/a

Current: $48.74

Upside: -

Molecular Partners AG

Dec 5, 2023

Maintains: Neutral

Price Target: $6.6 → $4.5

Current: $3.56

Upside: +26.49%

Novo Nordisk

Jun 7, 2022

Upgrades: Overweight

Price Target: n/a

Current: $50.90

Upside: -